Position in PGEN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$68,953,287
-$9,101,800 QoQ
Shares Held
17,817,387
-4.6% QoQ
Ownership
5.00%
of shares outstanding
% of Portfolio
2.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Derivatives in PGEN
reported options exposure · as of Mar 31, 2022CallValue
$949,500
CallShares
450,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Patient Capital Management, LLC holds $243,742,343 across 2 Biotechnology names. PGEN ranks #2 (28.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
3,643,716 | $174,789,056 | |
| 2 | PGEN |
Precigen, Inc.
This page
|
17,817,387 | $68,953,287 |
All Filings in PGEN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $68,953,287 | 17,817,387 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $78,055,087 | 18,673,466 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $150,508,424 | 36,006,800 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $87,056,189 | 26,460,848 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $23,101,612 | 16,268,741 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $25,884,728 | 17,372,301 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $50,650,278 | 45,223,463 | Shares | Sole | 2025-10-30 | |
| 2024-12-31 | $20,026,995 | 17,881,246 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,040,809 | 17,937,694 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $28,715,959 | 18,174,658 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $25,307,509 | 17,453,455 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $21,418,158 | 15,983,700 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,529,509 | 13,753,176 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,930,094 | 11,243,560 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,551,585 | 1,463,760 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,213,264 | 798,200 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $632,184 | 298,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $399,588 | 298,200 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $629,202 | 298,200 | Shares | Sole | 2022-05-16 | |
| 2022-03-31 | $949,500 | 450,000 | Call | Sole | 2022-05-16 | |
| 2021-12-31 | $1,106,322 | 298,200 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||